SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention (CDC). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder – United States 2003. MMWR Morb Mortal Wkly Rep 2005; 54: 8427.
  • 2
    Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children – United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010; 59: 143943.
  • 3
    Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007; 64: 10329.
  • 4
    Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders – Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009; 58: 120.
  • 5
    Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci 2009; 11: 720.
  • 6
    Conrad P. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore: The Johns Hopkins University Press, 2008.
  • 7
    Swann AC, Geller B, Post RM, et al. Practical clues to early recognition of bipolar disorder: a primary care approach. Prim Care Companion J Clin Psychiatry 2005; 7: 1521.
  • 8
    Frances A. The first draft of DSM-V. BMJ 2010; 340: c1168.
  • 9
    Verhoeff B. Drawing borders of mental disorders: An interview with David Kupfer. BioSocieties 2010; 5: 46775.
  • 10
    Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 2008; 5: e1.
  • 11
    Harris G, Carey B. Researchers fail to reveal full drug pay. New York Times 2008 http://www.nytimes.com/2008/06/08/us/08conflict.html (accessed 12 October 2011).
  • 12
    Frances A. Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry 1998; 55: 119.
  • 13
    Furman L. What is attention-deficit hyperactivity disorder (ADHD)? J Child Neurol 2005; 20: 9941002.
  • 14
    Tuin-Batstra L. Difficult Birth, Difficult Life? Ridderkerk, the Netherlands: Ridderprint Offsetdrukkerij (Dissertation University of Groningen), 2004. (in English)
  • 15
    Danforth S, Navarro V. Hyper talk: sampling the social construction of ADHD in everyday language. Anthropology & Education Quarterly 2001; 32: 16790.
  • 16
    Harborne A, Wolpert M, Clare L. Making sense of ADHD: a battle for understanding? Parents’ views of their children being diagnosed with ADHD Clin Child Psychol Psychiatry 2004; 9: 32739.
  • 17
    Furedi F. Medicalisation in a therapy culture. In: Wainwright D, editor. A Sociology of Health. London: Sage, 2008: 97114.
  • 18
    Broom DH, Woodward RV. Medicalisation reconsidered: toward a collaborative approach to care. Sociol Health Illn 1996; 18: 35778.
  • 19
    Child N. Deficient attention and disordered activity: child psychiatry’s response to ADHD. Clin Child Psychol Psychiatry 2003; 8: 16778.
  • 20
    Batzle CS, Weyandt LL, Janusis GM, DeVietti TL. Potential impact of ADHD with stimulant medication label on teacher expectations. J Atten Disord 2010; 14: 15766.
  • 21
    Jussim L. Self fulfilling prophecies: a theoretical and integrative review. Psychol Rev 1986; 93: 29445.
  • 22
    Sayal K, Owen V, White K, Merrell C, Tymms P, Taylor E. Impact of early school-based screening and intervention programs for ADHD on children’s outcomes and access to services: follow-up of a school-based trial at age 10 years. Arch Pediatr Adolesc Med 2010; 164: 4629.
  • 23
    Tymms P, Merrell C. The impact of screening and advice on inattentive, hyperactive and impulsive children. Eur J Spec Needs Educ 2006; 21: 32137.
  • 24
    Merton RK. Social Theory and Social Structure. New York: Free Press, 1968.
  • 25
    Ben-Zeev D, Young MA, Corrigan PW. DSM-V and the stigma of mental illness. J Ment Health 2010; 19: 31827.
  • 26
    Walker JS, Coleman D, Lee J, Squire PN, Friesen BJ. Children’s stigmatization of childhood depression and ADHD: magnitude and demographic variation in a national sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 91220.
  • 27
    Rüsch N, Corrigan PW, Todd AR, Bodenhausen GV. Implicit self-stigma in people with mental illness. J Nerv Ment Dis 2010; 198: 1503.
  • 28
    Sparks JA, Duncan BL. The ethics and science of medicating children. Ethical Hum Psychol Psychiatry 2004; 6: 2539.
  • 29
    Kendell RE. The Role of Diagnosis in Psychiatry. Oxford: Blackwell, 1975.
  • 30
    Zola IK. Medicine as an institute of social control. Sociol Rev 1972; 20: 487504.
  • 31
    National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder (ADHD). September 2008. Clinical guideline 72. Available at http://guidance.nice.org.uk/CG72 (accessed on 14 October 2011).